Navigation Links
LA BioMed researcher to receive prestigious honor
Date:9/27/2010

The American Association of Cardiovascular and Pulmonary Rehabilitation will bestow one of its highest honors on Los Angeles Biomedical Research Institute (LA BioMed) principal investigator, Richard Casaburi, PhD, MD, at the association's annual meeting in Milwaukee.

Dr. Casaburi, who holds the Alvin Grancell/Mary Burns Endowed Chair in the Rehabilitative Sciences at LA BioMed and leads its pulmonary rehabilitation research, will receive the Michael L. Pollock Established Investigator Award on Oct. 8 at the association's 25th Anniversary Celebration Banquet during its Annual Meeting in Milwaukee. In announcing the award, the association said it was recognizing Dr. Casaburi's "many outstanding contributions to cardiovascular and pulmonary rehabilitation."

The association, comprised of health professionals in the field of cardiac and pulmonary rehabilitation, is dedicated to reducing morbidity, mortality and disability from cardiovascular and pulmonary disease through education, prevention, rehabilitation, research and disease management.

"Congratulations to Dr. Casaburi for another milestone in his prestigious career in the field of respiratory research and pulmonary rehabilitation," said David I. Meyer, LA BioMed president and CEO. "Dr. Casaburi has led the way in developing new rehabilitation strategies for the millions suffering from respiratory disease. His research is another example of how LA BioMed's researchers are making a difference in the health and quality of life of patients around the world."

In addition to the Pollock award, Dr. Casaburi has received the California Medal from the American Lung Association of California; the Governors Award from the American College of Chest Physicians; the Mary Burns Award from the California Society for Pulmonary Rehabilitation; the Career Achievement Award from the Fourth Quebec International Symposium on Cardiopulmonary Prevention and Rehabilitation and an award from the American Thoracic Society for his contribution to the establishment of the society's Pulmonary Rehabilitation Assembly.

He is president of the Pulmonary Education and Research Foundation, a nonprofit corporation dedicated to advancing the scientific basis and practice of pulmonary rehabilitation. To date, he has authored 207 publications and 184 abstracts.

At LA BioMed, Dr. Casaburi directs the Rehabilitation Clinical Trials Center, a facility dedicated to performing clinical research aimed at improving the lives of patients with Chronic Obstructive Pulmonary Disease, the fourth leading cause of death in the United States.

In addition to his work at LA BioMed, Dr. Casaburi is associate chief for Research and professor of medicine in the Division of Respiratory and Critical Care Physiology and Medicine at Harbor-UCLA Medical Center. He is also director of Clinical Respiratory Physiology.

He received his PhD from Rensselaer Polytechnic Institute, before qualifying in medicine from the University of Miami, School of Medicine.

He is a Fellow of the American College of Chest Physicians and the American Association of Cardiovascular and Pulmonary Rehabilitation, and he is a member of the American Physiological Society and the American Thoracic Society. Dr. Casaburi currently serves on the editorial boards of the Journal of Cardiopulmonary Rehabilitation, Proceedings of the American Thoracic Society and the Journal of COPD.


'/>"/>

Contact: Laura Mecoy
Lmecoy@issuesmanagement.com
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert  

Related medicine news :

1. BioMed Realty Trust Reports Fourth Quarter and Full-Year 2009 Financial Results
2. BioMed Realty Trust Promotes Matthew G. McDevitt to Executive Vice President, Real Estate
3. First Annual Bay Area Biomedical Device Conference to be Held at San Jose State University
4. Seattle BioMed Offers the Gift of Hope for Mother's Day
5. LA BioMed awarded research grant to study HIV prevention gel
6. Cambridge Healthtech Institute to Host Its Second Annual Collaborative Innovation in Biomedicine Conference
7. New Diagnostic Testing Company, Blue Ocean Biomedical, Specializes In Automated, Load & Go Cell Analysis Systems For Immune Monitoring
8. Manmade antibodies hold biomedical promise
9. Applied nuclear physics for biomedicine, nuclear security and basic science
10. Blue Ocean Biomedical Opens New Manufacturing Facility In Miramar, FL
11. Team led by LA BioMed scientist develops novel approach to study neurological disorders
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
LA BioMed researcher to receive prestigious honor
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... Revolutionary technology includes multi-speaker listening ... industry leaders in advanced audiology and hearing aid technology, ... ™, the world,s first internet connected hearing aid that ...      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ) , ... ,world firsts,: , TwinLink™ - the first ...
Breaking Medicine Technology: